First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Sets New 52-Week High – What’s Next?

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) shares hit a new 52-week high on Monday . The stock traded as high as $43.01 and last traded at $43.01, with a volume of 189 shares traded. The stock had previously closed at $42.26.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

The firm has a fifty day moving average of $38.65 and a 200 day moving average of $35.94. The stock has a market capitalization of $1.01 billion, a price-to-earnings ratio of 14.51 and a beta of 0.45.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Thursday, June 25th were paid a $0.092 dividend. The ex-dividend date was Thursday, June 25th. This represents a $0.37 annualized dividend and a dividend yield of 0.9%. This is an increase from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.06.

Institutional Trading of First Trust Nasdaq Pharmaceuticals ETF

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Compass Financial Management LLC acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF in the second quarter worth about $29,000. NBC Securities Inc. boosted its stake in shares of First Trust Nasdaq Pharmaceuticals ETF by 33.0% during the 4th quarter. NBC Securities Inc. now owns 1,325 shares of the company’s stock worth $44,000 after acquiring an additional 329 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 2nd quarter valued at about $57,000. Kestra Advisory Services LLC acquired a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 4th quarter valued at about $59,000. Finally, Flputnam Investment Management Co. purchased a new position in shares of First Trust Nasdaq Pharmaceuticals ETF in the 4th quarter valued at about $230,000.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.